SEP 29, 2021 10:30 AM PDT

Advances in CRISPR Screens: Gene Modulation and Single-Cell Analysis Provide New Insights

Presented at: CRISPR 2021
Sponsored by: MilliporeSigma
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Multi-target screening can offer great insight into the genetic pathways in drug resistance and disease. RNAi and the fast pace of CRISPR technology development has brought sophisticated options for library screens including the possibility of genome-wide, epigenetic target gene modulation. CRISPRi allows for targeted suppression of gene function while CRISPRa offers a gain-of-function approach to screening. Both complement existing loss-of-function and gain-of-function technologies such as RNAi and ORFs; and have several distinct advantages, including efficient targeting of non-coding genes. You can also take your screens to the single-cell level by using our 10X Genomics compatible CRISPR guide vectors containing capture sequences that allow efficient feature barcoding of individual cells for transcriptomics across pools of guides, allowing functional genomic analysis of top screen hits for single-cell genomic exploration. 

In this webinar, we will explore screening technologies for gene knockout, activation, and repression to help you choose the right format and approach for your screening applications.

 

Learning Objectives:

1. Review gene knockout, activation, and repression to help you choose the right format and approach for your screening applications.

2. Indentify how orthogonal validation via multiple technologies lends to additional gene pathway insights.

3. Differentiate between delivery options and formats for screening tools for different applications.


Show Resources
You May Also Like
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 08, 2021 7:00 AM PST
DEC 08, 2021 7:00 AM PST
Date: December 08, 2021 Time: 7:00am (PDT), 10:00am (EDT) Successful bioprocessing is complex and depends on many factors. From the selection of the expression host, media composition, the p...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 30, 2021 11:00 AM PST
C.E. CREDITS
NOV 30, 2021 11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
Loading Comments...
Show Resources